Managers / Q1 2023 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $128M in U.S.-listed holdings across 21 positions for Q1 2023.
The portfolio is heavily concentrated: IVE alone accounts for 39.3% of reported value.
Compared with Q4 2022, the fund opened 0 new positions and exited 10.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 79.2% · $101M
- REIT · 14.6% · $19M
- Common Stock · 4.8% · $6M
- Other · 0.8% · $1M
- Closed-End Fund · 0.6% · $761,279
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BKLNINVESCO EXCH TRADED FD TR II | ADDED | +508.1K | 600.6K | +$11M | $12M |
| BSVVANGUARD BD INDEX FDS | ADDED | +92.9K | 164.8K | +$7M | $13M |
| VNQVANGUARD INDEX FDS | SOLD OUT | −226.5K | 0 | −$19M | $0 |
| ENERPLUS CORP | SOLD OUT | −195.4K | 0 | −$3M | $0 |
| CHRDCHORD ENERGY CORPORATION | SOLD OUT | −20.4K | 0 | −$3M | $0 |
| MSD ACQUISITION CORP | SOLD OUT | −51.0K | 0 | −$514,893 | $0 |
| ROSS ACQUISITION CORP II | SOLD OUT | −50.9K | 0 | −$514,653 | $0 |
| WARBURG PINCUS CAPTAL CORP I | SOLD OUT | −50.9K | 0 | −$514,141 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVEISHARES TR | IBOXX HI YD ETF · S&P 500 VAL ETF · CORE HIGH DV ETF · CORE S&P500 ETF · ISHARES BIOTECH · PFD AND INCM SEC | 39.33% | $50M | 523.6K |
| 2 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 10.83% | $14M | 305.9K |
| 3 | BSVVANGUARD BD INDEX FDShistory → | SHORT TRM BOND | 9.89% | $13M | 164.8K |
| 4 | BKLNINVESCO EXCH TRADED FD TR IIhistory → | SR LN ETF | 9.80% | $12M | 600.6K |
| 5 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 7.50% | $10M | 236.6K |
| 6 | AVBAVALONBAY CMNTYS INChistory → | COM | 5.86% | $7M | 44.5K |
| 7 | PLDPROLOGIS INC.history → | COM | 4.15% | $5M | 42.4K |
| 8 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 3.67% | $5M | 37.2K |
| 9 | XBISPDR SER TRhistory → | S&P BIOTECH | 1.87% | $2M | 31.3K |
| 10 | CRCCALIFORNIA RES CORPhistory → | COM STOCK | 1.76% | $2M | 58.5K |
| 11 | TALOTALOS ENERGY INChistory → | COM | 1.63% | $2M | 139.8K |
| 12 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.38% | $2M | 156.2K |
| 13 | BXPBOSTON PROPERTIES INC | COM | 0.92% | $1M | 21.7K |
| 14 | NMLNEUBERGER BERMAN MLP & ENERG | COM | 0.60% | $761,279 | 115.9K |
| 15 | RICE ACQUISITION CORP II | SHS CL A | 0.41% | $522,292 | 51.0K |
| 16 | ORION BIOTECH OPPORTUNTES CO | CLASS A ORD SHS | 0.41% | $519,479 | 50.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.